Merck's endometrial cancer drug meets late-stage trial goals

Merck's endometrial cancer drug meets late-stage trial goals

May ‌18 (Reuters) - ‌Merck said ​on ‌Monday ⁠its ⁠experimental ​endometrial cancer ​drug ​met ‌the ‌main ​goals ​of ​a ‌late-stage ​trial.

Reuters

Advertisement

(Reporting ​by ​Kamal ‌Choudhury ​in ​Bengaluru)

 

ERIUS MAG © 2015 | Distributed By My Blogger Themes | Designed By Templateism.com